PAA would be eligible anyway just by doing the OLE in Australia, irrespective of expanding the study. The single 'Aussie' proviso for funding from Fight MND is that the Primary Investigator for the research to be funded, must be based in Australia.
Pharmaust - Media & News, page-74
-
- There are more pages in this discussion • 186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $5.307K | 28.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 551793 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 25917 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |